Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Pulm/Thoracic Infections

Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: A retrospective, total population cohort study in Sweden

The Lancet | Feb 09, 2022 Pulm/Thoracic Infections

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

The Lancet | Feb 08, 2022 Pulm/Thoracic Infections

The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays

Journal of the European Academy of Dermatology and Venereology | Feb 08, 2022 Pulm/Thoracic Infections

Pandemic preparedness and COVID-19: An exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021

The Lancet | Feb 05, 2022 Pulm/Thoracic Infections

Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink

PLoS Medicine | Feb 04, 2022 Pulm/Thoracic Infections

Overall and cause-specific hospitalization and death after COVID-19 hospitalization in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform

PLoS Medicine | Feb 04, 2022 Pulm/Thoracic Infections

Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19

BMC Nephrology | Feb 04, 2022 Pulm/Thoracic Infections

In-hospital cardiac arrest survival in the United States during and after the initial novel coronavirus disease 2019 pandemic surge

Circulation: Cardiovascular Quality and Outcomes | Feb 03, 2022 Pulm/Thoracic Infections

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

The Lancet | Feb 01, 2022 Pulm/Thoracic Infections

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

The Lancet | Feb 01, 2022 Pulm/Thoracic Infections

« Prev 1 2 3 4 Next »

Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: A retrospective, total population cohort study in Sweden

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays

Pandemic preparedness and COVID-19: An exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021

Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink

Overall and cause-specific hospitalization and death after COVID-19 hospitalization in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform

Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19

In-hospital cardiac arrest survival in the United States during and after the initial novel coronavirus disease 2019 pandemic surge

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

Micronutrient Deficiencies in The Modern Diet: Causes & Correction

Age Related Macular Degeneration

Managing Polypharmacy in Elderly Patients

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: A retrospective, total population cohort study in Sweden

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays

Pandemic preparedness and COVID-19: An exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021

Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink

Overall and cause-specific hospitalization and death after COVID-19 hospitalization in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform

Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19

In-hospital cardiac arrest survival in the United States during and after the initial novel coronavirus disease 2019 pandemic surge

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

Micronutrient Deficiencies in The Modern Diet: Causes & Correction

Age Related Macular Degeneration

Managing Polypharmacy in Elderly Patients

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Select Specialty

Select Topic